The accumulation of tau protein in the brain interferes with the salience network, a system…
Browsing: Dementia
Dementia is a group of neurological conditions characterized by a decline in cognitive function—affecting memory, reasoning, communication, and the ability to perform everyday tasks. The most common form is Alzheimer’s disease, but other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. As global populations age, dementia has become a major public health concern, driving research into its causes, risk factors, early detection, and potential treatments. Explore the latest findings on dementia, from breakthroughs in brain science to emerging therapies aimed at prevention and care.
Cardiovascular diseases, including heart failure, atrial fibrillation, and coronary heart disease, are closely linked to…
Researchers have captured the first images of a brain network designed to clear waste, potentially…
A new peptide inhibitor, RI-AG03, targets two key areas of the Tau protein in Alzheimer’s…
Work could lead to the discovery of new therapeutic targets. For the first time, researchers…
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia,…
A weight-maintaining hormone is essential for brain-signal transmission. New research is more closely linking obesity…
Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early…
Cognitive decline in older adults can often lead to conditions like Alzheimer’s disease. A study…
A study shows that rising levels of brain protein Aβ42, not the reduction of amyloid…
Researchers have identified distinct cellular pathways in aging brains that lead to Alzheimer’s, offering new…
Researchers have found that targeting a class of sugar-modified proteins enhances cell repair, restores lost…
Researchers at the University of Melbourne have developed a promising blood test for early Alzheimer’s…
A unique quantum effect in biology may hold the key to deciphering a common indicator…
IDO1 inhibitors, drugs originally aimed at cancer, show potential in treating Alzheimer’s by improving brain…
Research from Korea indicates SGLT-2 inhibitors not only manage type 2 diabetes but may also…
Lewy body disease, particularly dementia with Lewy bodies (DLB), affects a significant portion of dementia…
Neuroscientists at Stanford have linked Alzheimer’s disease to the disruption of brain metabolism via the…